[Extranodal diffuse large B-cell lymphoma--an organotypic disease?].

Area of Science:

• Hematology
• Oncology
• Pathology

Context:

• Diffuse large B-cell lymphomas (DLBCL) frequently originate in extranodal sites (30-40%), commonly the gastrointestinal tract, CNS, testes, lungs, or skin.
• Morphologically, extranodal DLBCL present similarly to nodal counterparts, displaying centroblasts, immunoblasts, or plasmoblasts.
• Despite morphological similarities, significant molecular and genetic differences exist between primary extranodal DLBCL and primary nodal DLBCL.

Purpose:

• To highlight the profound differences in primary extranodal DLBCL compared to nodal DLBCL.
• To explore the organotypic features, molecular characteristics, and genetic constitutions of primary extranodal DLBCL.
• To investigate potential organotypic transformation pathways suggested by gene expression profiling in extranodal DLBCL.

Summary:

• Primary extranodal DLBCL exhibit unique molecular and genetic profiles, often linked to their specific organ of origin.
• WHO-classified subtypes like mediastinal, intravascular, or primary effusion lymphoma exemplify site-specific DLBCL characteristics.
• Gene expression profiling suggests distinct gene signatures for extranodal DLBCL, indicating unique oncogenic pathways.

Impact:

• Understanding these extranodal DLBCL subtypes is crucial for accurate diagnosis and targeted therapy.
• Identifies potential for site-specific diagnostic markers and therapeutic strategies in DLBCL.
• Advances knowledge of DLBCL pathogenesis, emphasizing the role of organotypic transformation pathways.